Acceso abierto

Alginate–gelatin hydrogel supplemented with platelet concentrates can be used as bioinks for scaffold printing

Tuyet Thi Vi Le

Tuyet Thi Vi Le

  • Department of Physiology and Animal Biotechnology, Biology and Biotechnology Faculty, University of ScienceHo Chi Minh City, Vietnam
  • Laboratory of Tissue Engineering and Biomedical Materials, University of ScienceHo Chi Minh City, Vietnam
  • Vietnam National UniversityHo Chi Minh City, Vietnam
Buscar este autor en
Sciendo|Google Scholar
Le, Tuyet Thi Vi
, 
Nghia Thi Hieu Phan

Nghia Thi Hieu Phan

  • Department of Physiology and Animal Biotechnology, Biology and Biotechnology Faculty, University of ScienceHo Chi Minh City, Vietnam
  • Laboratory of Tissue Engineering and Biomedical Materials, University of ScienceHo Chi Minh City, Vietnam
  • Vietnam National UniversityHo Chi Minh City, Vietnam
Buscar este autor en
Sciendo|Google Scholar
Phan, Nghia Thi Hieu
 y 
Ha Le Bao Tran

Ha Le Bao Tran

  • Department of Physiology and Animal Biotechnology, Biology and Biotechnology Faculty, University of ScienceHo Chi Minh City, Vietnam
  • Laboratory of Tissue Engineering and Biomedical Materials, University of ScienceHo Chi Minh City, Vietnam
  • Vietnam National UniversityHo Chi Minh City, Vietnam
Buscar este autor en
Sciendo|Google Scholar
Tran, Ha Le Bao
  
26 oct 2023
Alginate–gelatin hydrogel supplemented with platelet concentrates can be used as bioinks for scaffold printing's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Categoría del artículo: Original article
Publicado en línea: 26 oct 2023
Páginas: 222 - 229
DOI: https://doi.org/10.2478/abm-2023-0063
Palabras clave
© 2023 Tuyet Thi Vi Le et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.

Figure 1.

The sol–gel transition of bioinks over time through inversion test. (A) AG bioink; (B) AGP bioink; (C) AGF bioink. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP.
The sol–gel transition of bioinks over time through inversion test. (A) AG bioink; (B) AGP bioink; (C) AGF bioink. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP.

Figure 2.

The pH of bioinks. (A) AG bioink; (B) AGP bioink; (C) AGF bioink. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP.
The pH of bioinks. (A) AG bioink; (B) AGP bioink; (C) AGF bioink. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP.

Figure 3.

GFs release from scaffolds over time. (A) AGP and AGF scaffolds, (B) Growth factors release. AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; GFs, growth factors; PDGF-AB; platelet-derived GF-AB; VEGF, vascular endothelial GF.
GFs release from scaffolds over time. (A) AGP and AGF scaffolds, (B) Growth factors release. AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; GFs, growth factors; PDGF-AB; platelet-derived GF-AB; VEGF, vascular endothelial GF.

Figure 4.

The RGR of cells in the serum-free extracts. ****P < 0.0001. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; RGR, relative growth rate.
The RGR of cells in the serum-free extracts. ****P < 0.0001. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; RGR, relative growth rate.

Figure 5.

The RGR of cells in the serum-containing extracts. ***P < 0.001, ****P < 0.0001. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; RGR, relative growth rate.
The RGR of cells in the serum-containing extracts. ***P < 0.001, ****P < 0.0001. AG, alginate–gelatin; AGF, alginate–gelatin-PRF; AGP, alginate–gelatin-PRP; RGR, relative growth rate.
Idioma:
Inglés
Calendario de la edición:
6 veces al año
Temas de la revista:
Medicina, Profesiones auxiliares, enfermería, Ciencias médicas básicas, Ciencias médicas básicas, otros, Medicina Clínica, Medicina Clínica, otros
RSS Feed de revista